Taurolin 2 %
Taurolin 2 % is a medicine authorised by Swissmedic under authorisation number 43668. The authorisation holder is Geistlich Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 October 1981 and the authorisation is valid without a time limit. ATC code B05CA05 places the medicine in the group Blood substitutes and perfusion solutions.
| Authorisation number | 43668 |
|---|---|
| Name | Taurolin 2 % |
| Full name | Taurolin 2 %, Lösung zur intraperitonealen Anwendung |
| Authorisation holder | Geistlich Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B05CA05 |
| First authorisation | 12 October 1981 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Taurolin 2 %, Lösung zur intraperitonealen Anwendung | B | 12 October 1981 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 x 250 | ml | B05CA05 | 08.01.9. | B |
Scroll the table sideways
Frequently asked questions
Is Taurolin 2 % authorised in Switzerland?
Yes. Taurolin 2 % is authorised by Swissmedic under authorisation number 43668, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Taurolin 2 % have?
Taurolin 2 % is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Taurolin 2 %?
The authorisation holder is Geistlich Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.